Study of Antidepressants in Parkinson's Disease.
Phase of Trial: Phase III
Latest Information Update: 04 Jun 2015
At a glance
- Drugs Paroxetine (Primary) ; Venlafaxine (Primary)
- Indications Depressive disorders; Parkinson's disease
- Focus Therapeutic Use
- Acronyms SAD-PD
- 01 Feb 2011 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
- 01 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Mar 2008 The expected completion date for this trial is May 2009 (February 2009 for final data collection date for primary outcome measure), according to ClinicalTrials.gov